Rho kinase inhibitors (CHDI Foundation/Charles River)

N/A

Report date: 2025/06/11 11:06:16
NME

Base Information

Drug NameRho kinase inhibitors (CHDI Foundation/Charles River)
Drug Alias NameCHDI-00490878CHDI-00580985
ClassificationSmall molecules
Mechanisms of ActionRhodopsin kinase inhibitors
TargetsRhodopsin kinase
Therapy Area/IndicationsHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesChdi Foundation Inc
China Registration ClassN/A

Develop Information

Active CompaniesCharles River Laboratories International IncChdi Foundation Inc
Inactive CompaniesN/A
Active IndicationsHuntington Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A